Daniel J. Levangie, President, Surgical Products at CYTYC CORP (CYTC), sold 120,000 shares at $27.06 ($3.2M) on 2006-12-06, disclosed to the SEC on 2006-12-11.
Scheduled sale ($3.2M) by President, Surgical Products under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.73 | 30,000 | $802K | 24.7% |
| 2 | $27.29 | 30,000 | $819K | 25.2% |
| 3 | $27.06 | 30,000 | $812K | 25.0% |
| 4 | $27.18 | 30,000 | $815K | 25.1% |
| Total | $27.07 avg | 120,000 | $3.2M | 100% |
| Filing → |
| EXAS | SELL | 2019-08-02 | $5.0M | — | Filing → |
| PODD | SELL | 2016-03-11 | $524K | — | Filing → |
| PODD | SELL | 2016-03-09 | $477K | — | Filing → |